The Patient Activation Measure in Patients with Rheumatoid Arthritis: A Systematic Review and Cross-Sectional Interview-Based Survey
Lobna Al Juffali,Haya M Almalag,Najd Alswyan,Jawaher Almutairi,Dalal Alsanea,Hussain F Alarfaj,Abdurhman S Alarfaj,Hanan H Abouzaid,Mohammed A Omair
DOI: https://doi.org/10.2147/PPA.S379197
2022-10-20
Patient Preference and Adherence
Abstract:Lobna Al Juffali, 1 Haya M Almalag, 1 Najd Alswyan, 1 Jawaher Almutairi, 1 Dalal Alsanea, 1 Hussain F Alarfaj, 2 Abdurhman S Alarfaj, 2 Hanan H Abouzaid, 1 Mohammed A Omair 2 1 Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia; 2 Rheumatology Unit, Department of Medicine, King Saud University, Riyadh, Saudi Arabia Correspondence: Haya M Almalag, Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, 11149, Saudi Arabia, Tel +966118057859, Email Introduction/Objective: The patient activation measure (PAM) is considered a reliable tool for measuring patient activation. This study aimed to systematically review the scientific literature regarding the use of PAM − 13 in rheumatology patients and to compare PAM scores in patients with rheumatoid arthritis (RA) following two different practices at a single institution with previously published studies. Methods: The study consisted of a systematic review of articles reporting the PAM-13 in patients with RA, followed by a cross-sectional study evaluating PAM scores between standard rheumatology clinics and specialized rheumatology clinics (SRCs). The correlation between PAM levels and other variables, such as demographics, disease characteristics, and treatment, was assessed. Results: Nineteen studies, published between 2012 and 2022, met the inclusion criteria. The studies in this review had inconsistent results and quality, with patient activation in RA ranging from 29 to 76. A total of 197 patients with confirmed RA diagnoses were interviewed (response rate, 88%). Most were female (n=173, 88%) and older than 40 years (n=150, 76%). The average patient activation score was 64.9 (standard deviation, 15.7). Most participants had level 3 and 4 patient activation measures (n=71 [36%] and n=72[37%], respectively). Patients who were attending SRCs also had borderline higher PAM levels. Patients with high PAM scores tended to be older, have active disease, and were taking corticosteroids. Conclusion: Adequate activation of patients was observed from our center, which was higher than that reported in most published literature. The PAM of patients with RA was variable according to the systematic review. Longitudinal interventional studies should be considered to improve activation in patients with low scores. Keywords: rheumatoid arthritis, patient activation measures, patient engagement, systematic review, cross-sectional study Patient empowerment is an essential aspect of health condition management. This enables patients to become more active in managing themselves by understanding their roles. It is also critical for patients to be knowledgeable and have skills and motivation to be proactive in their management. 1,2 This approach involves patient activation, which is defined as patients' preparedness to manage their health based on their knowledge, skills, and confidence, and understanding their role in the care process to manage their health and health care. 3 The patient activation measure (PAM) is a tool that can be used to measure patient empowerment. 4 Hibbard et al developed the PAM. 4 It was first developed as a 22-item PAM questionnaire, and a short version was later developed with 13 items. 5 The 13-item PAM questionnaire is a reliable and valid measure for different chronic illnesses. 6 In addition, it is now considered one of the most frequently used questionnaires, with published evidence of its construct validity. 4 However, it is important to keep in mind that patients differ in their willingness and ability to take on this role in managing their health. 7 Understanding each patient's readiness to take an active part in managing their health can help in designing customized interventions for each patient based on patient activation level, which has been reported to improve patient outcome measures. 7 Studies have demonstrated that patients who are actively involved in their treatment tend to cooperate more effectively with healthcare providers and eventually experience better health outcomes. 8 Those with higher activation levels reported significantly better health outcomes, with significantly lower rates of doctor's office and emergency room visits. 4 PAM levels were also observed to be a predictor for new chronic disease; patients with lower PAM levels were more likely to have a new chronic disease. 9 In addition, studies have shown that higher PAM levels are associated with lower health costs. 9–11 Changes in the PAM levels of patient populations might be -Abstract Truncated-
medicine, general & internal